glp 1 agonist pregnancy Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin Navigating GLP-1 and Pregnancy: Insights,

For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity

ADDITIONAL DETAILS: Live Probiotics, Prebiotic Fiber, and a Key Postbiotic for Daily Support

Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.

An endocrinologist explains who the pill is right for in the UAE, what the trial numbers actually say, and when the injection still wins.

Considerations regarding adverse effects and contraindications for different drug classes are provided to help guide treatment decision-making when considering pharmacotherapy for weight management in patients with obesity.

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, can help to maintain weight loss.